Survey
Quarterly Survey: Narcolepsy Oxybate Treatments / Avadel’s Lumryz July 2023
Ticker(s): AVDL, JAZZThe survey results include 20 physicians that treat Narcolepsy.
How many patients with Narcolepsy are under your care?
How many patients with Narcolepsy do you have on an Oxybate drug (Xyrem, Xywav, Lumryz) right now?
How many pts are currently on Xyrem (branded or generic; do not include Xywav)?
How many of your pts on Xyrem are on the generic version?
How many of your pts on Xyrem do you expect to eventually switch to Lumryz's once-nightly dosing regimen?
How many pts are currently on Xywav (do not include Xyrem)?
How many of your pts on Xywav do you expect to eventually switch to Lumryz’s once-nightly dosing regimen?
How many pts did you initiate a switch from Xywav/Xyrem to Lumryz over the past 30 days?
How many pts do you expect to switch from Xywav/Xyrem to LUMRYZ over the next 30 days?
How many new to Oxybate pts did you have start on the following Oxybate Therapy treatments in the past 30 days:
- Xywav
- Xyrem
- Lumryz
How many new to Oxybate pts did you have start on the following Oxybate Therapy treatments in the next 30 days:
- Xywav
- Xyrem
- Lumryz
Have you found the effort to get patients covered easy enough such that you plan to continue Lumryz starts or difficult to the point that you might hold off for a while until insurance companies improve their coverage of the drug? Please be specific.
How many pts do you expect to have on Lumryz at the following points in time:
- September 30, 2023
- December 31, 2023
- June 30, 2023
How much bigger will your total population of pts on Oxybate Therapy be 3 years from now compared to what it would have been had Lumryz and it's 1X Nightly Dosing not been available (i.e., by what % do you think Lumryz will grow your total population of pts on Oxybate)?
Recognizing that now having a 1x nightly dosing option can expand the market in two ways—1) cause more patients to chose to be on Oxybate with existing prescribers, and 2) cause more docs who previously found Oxybate to be too cumbersome to prescribe start to prescribe the drug— How big do you think the current 16K national population of patients on Oxybate drugs for Narcolepsy will be in 3 years?
Please elaborate on your view of Lumryz. Please be specific.
On a scale 1-10 (where 1 is low and 10 is high) how excited are you about the potential benefits of Lumryz for your patients with narcolepsy?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
